Cargando…

Chimeric antigen receptor T cell therapy for the treatment of systemic rheumatic diseases: a comprehensive review of recent literature

Systemic rheumatoid diseases (SRDs) are autoimmune and inflammatory disorders that affect multiple organ systems, impacting patients’ quality of life, and survival rates. Standard treatment requires continuous drug therapy and immunosuppression. Chimeric antigen receptor (CAR) T cell therapy has the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhandari, Sambhawana, Bhandari, Sadikshya, Bhandari, Samikshya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328598/ https://www.ncbi.nlm.nih.gov/pubmed/37427200 http://dx.doi.org/10.1097/MS9.0000000000000891

Ejemplares similares

Drug-Induced Gum Overgrowth With Low-Dose Amlodipine: A Case Report
por: Bhandari, Sadikshya, et al.
Publicado: (2022)

Meningeal Signs and Cerebellar Involvement in Scrub Typhus: A Case Report
por: Bhandari, Sadikshya, et al.
Publicado: (2022)

Chimeric antigen receptor T cell: A cancer immunotherapy
por: Singh, Surjit, et al.
Publicado: (2022)

Iatrogenic Pneumocephalus Resolved by Oxygen Therapy
por: Bhandari, Sambhawana, et al.
Publicado: (2021)

Thrombolytic Therapy in the Oldest Old: Successful Alteplase Administration in a 105-Year-Old Female With Ischemic Stroke
por: Bhandari, Sambhawana, et al.
Publicado: (2021)

Octreotide as a novel agent for the management of bronchorrhea in mechanically ventilated patients: A case series and review of literature
por: Bhandari, Sambhawana, et al.
Publicado: (2023)

Possible Aripiprazole-Induced Hypothermia: An “Icy” Side Effect?
por: Bhandari, Sambhawana, et al.
Publicado: (2021)

Recent updates on codeine
por: Bhandari, Monika, et al.
Publicado: (2011)

Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence
por: Bhandari, Sambhawana, et al.
Publicado: (2022)

Concurrent Measurement of Mitochondrial DNA Copy Number and ATP Concentration in Single Bovine Oocytes
por: Read, Casey C., et al.
Publicado: (2021)

Nontuberculous Mycobacterial Infection Mimicking Inflammatory Tenosynovitis: A Real Head Scratcher
por: Bhandari, Sambhawana, et al.
Publicado: (2021)

The Ominous Aspergillus With Cancer of Blood Vessels: A Case of Invasive Aspergillosis and Epithelioid Angiosarcoma of the Lung
por: Bhandari, Sambhawana, et al.
Publicado: (2023)

Recent progress in improving the safety and efficacy of chimeric antigen receptor T cell therapy
por: Yang, Yingying, et al.
Publicado: (2018)

Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023)

Autoimmune gastritis in a male adolescent with cerebellar involvement: A case report
por: Sapkota, Prakash, et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cell Therapy in Hematology
por: Ataca, Pınar, et al.
Publicado: (2015)

Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
por: Reinhardt, Bryanna, et al.
Publicado: (2023)

Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development
por: Kast, Johannes, et al.
Publicado: (2022)

Quantitative Systems Pharmacology Model of Chimeric Antigen Receptor T‐Cell Therapy
por: Hardiansyah, Deni, et al.
Publicado: (2019)

Recent advances in the management of large and complex colonic polyps
por: Longcroft-Wheaton, Gaius, et al.
Publicado: (2018)

Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
por: Polgárová, Kamila, et al.
Publicado: (2022)

Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Metastatic Prostate Cancer: A Comprehensive Review
por: Yu, Young Dong, et al.
Publicado: (2021)

Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
por: He, Mingze, et al.
Publicado: (2023)

Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
por: Han, Xiao, et al.
Publicado: (2019)

Chimeric Antigen Receptor Therapy for B-cell Malignancies
por: Porter, David L, et al.
Publicado: (2011)

Chimeric antigen receptor T-cell therapy for solid tumors
por: Newick, Kheng, et al.
Publicado: (2016)

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
por: Dai, Hanren, et al.
Publicado: (2016)

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
por: Stoiber, Stefan, et al.
Publicado: (2019)

Chimeric antigen receptor T cell therapy for multiple myeloma
por: Hasegawa, Kana, et al.
Publicado: (2019)

Mechanisms of failure of chimeric antigen receptor T-cell therapy
por: Li, Xiaoqing, et al.
Publicado: (2019)

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
por: Hosen, Naoki
Publicado: (2019)

Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
por: Sur, Daniel, et al.
Publicado: (2020)

Chimeric antigen receptor T cell therapies for multiple myeloma
por: Wu, Chao, et al.
Publicado: (2019)

Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma
por: Sawaisorn, Piamsiri, et al.
Publicado: (2020)

Chimeric antigen receptor‐T cell therapies: The changing landscape
por: Sengsayadeth, Salyka M., et al.
Publicado: (2021)

Cardiovascular disease and chimeric antigen receptor cellular therapy
por: Rao, Anjali, et al.
Publicado: (2022)

Chimeric antigen receptor T-cell therapy for multiple myeloma
por: Wang, Zehua, et al.
Publicado: (2022)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
por: Wei, Wenwen, et al.
Publicado: (2022)

Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances
por: Nikoo, Marzieh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5mulfvfap16b1371vri3d49afj